Michael Rothschild, MD
NPI 1801281225 · Ophthalmic Plastic and Reconstructive Surgery Physician · Slingerlands, NY
Provider details
- NPI number
- 1801281225
- Entity type
- Individual
- Primary specialty
- Ophthalmic Plastic and Reconstructive Surgery PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 295717 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
11 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
620 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| New Patient Complete Exam of Visual System92004 | 209 | $141 |
| Established Patient Problem Focused Exam of Visual System92012 | 185 | $84 |
| Photography of Content of Eyes92285 | 76 | $22 |
| Removal of Growth of Eyelid67840 | 40 | $259 |
| Removal of Excessive Skin and Fat of Upper Eyelid15823 | 35 | $716 |
| Probing of Nasal Tear Duct68840 | 28 | $142 |
| Shortening Or Advancement of Upper Eyelid Muscle to Correct Drooping Or Paralysis |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$107 across 4 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2015-04-02
- Last updated
- 2026-02-27
- Certified
- 2026-02-27
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.